Clinical Trials Update: July 8, 2009

July 9 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:

Fibromyalgia

This study of fibromyalgia will last for 7 months and require 12 visits.

The research site is in Sacramento, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/fibromyalgia.aspx.

-----

Irritable Bowel Syndrome (IBS)

Researchers are evaluating an investigational medication to see if it effectively treats irritable bowel syndrome with constipation (IBS-C).

The research site is in Laurel, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/irritable_bowel_syndrome.aspx.

-----

GERD (Gastroesophageal Reflux Disease)

Participants in this study of GERD, commonly called acid reflux or heartburn, will receive study related health assessments, and potential reimbursement for travel and expenses.

The research sites are located nationwide.

More information

Please see http://www.clinicalconnection.com/5713.aspx.

-----

Migraine and Cluster Headaches

If you are a non-smoking female aged 18 to 34 and have migraine headaches related to your menstrual cycle, you may qualify for this study.

The research site is in Edison, N.J.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=100.